These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Paradoxical reversal of the suppressed potassium secretion during treatment with combinations of antikaluretic agents (spironolactone, canrenone, triamterene, amiloride); a possible site of action in Henle's loop. Radó JP; Sawinsky I; Juhos E Horm Metab Res; 1976 May; 8(3):250-1. PubMed ID: 939474 [No Abstract] [Full Text] [Related]
26. New drug evaluations amiloride (Midamor, Merck, Sharp and Dohme). Macfie HL; Colvin CL; Anderson PO Drug Intell Clin Pharm; 1981 Feb; 15(2):94-8. PubMed ID: 7274028 [TBL] [Abstract][Full Text] [Related]
27. Significance of hypokalaemia due to diuretics. Leemhuis MP; Struyvenberg A Neth J Med; 1973; 16(1):18-28. PubMed ID: 4572424 [No Abstract] [Full Text] [Related]
28. [Influence of triamterene, aldactone and amilorid on the electrolyte excretion following oral potassium loading test in rats]. Formanek K; Hohenegger M Wien Klin Wochenschr; 1970 Mar; 82(13):240-1. PubMed ID: 5419661 [No Abstract] [Full Text] [Related]
29. [Diuresis therapy in hyperaldosteronism]. Wallnöfer H; Hanusch M Wien Med Wochenschr; 1966 Dec; 116(52):1159-64. PubMed ID: 5996768 [No Abstract] [Full Text] [Related]
30. Opposite effects of spironolactone and amiloride on potassium excretion in a patient with ascites due to liver cirrhosis. Radó JP; Juhos E Endokrinologie; 1976 Jul; 67(3):377-9. PubMed ID: 976213 [TBL] [Abstract][Full Text] [Related]
31. Reversal of the suppressed potassium excretion during treatment with combinations of antikaliuretic drugs (spironolactone, canrenone, triamterene, amiloride) in patients with liver cirrhosis. Radó JP; Sawinsky I; Juhos E Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):163-7. PubMed ID: 1002353 [TBL] [Abstract][Full Text] [Related]
32. [Principles of treating hypertension patients with diuretics]. Nekrasova AA Ter Arkh; 1986; 58(1):116-20. PubMed ID: 3961683 [No Abstract] [Full Text] [Related]
34. Amiloride in primary hyperaldosteronism with chronic peptic ulceration. Kremer D; Fraser R; Brown JJ; Lever AF; Davies DL; Robertson JI Br Med J; 1973 Apr; 2(5860):216-7. PubMed ID: 4700011 [No Abstract] [Full Text] [Related]
35. Current management of hypertension. Moore MA Am Fam Physician; 1985 Dec; 32(6):129-36. PubMed ID: 2866702 [TBL] [Abstract][Full Text] [Related]
36. Clinical use of potassium supplements and potassium sparing diuretics. Morgan TO Drugs; 1973; 6(3):222-9. PubMed ID: 4778987 [No Abstract] [Full Text] [Related]
37. [The problem of potassium and diuretics]. Bernik V Rev Paul Med; 1972 Sep; 80(3):127-32. PubMed ID: 4602416 [No Abstract] [Full Text] [Related]
38. [Treatment of the hypertensive patient. Value of Amiloride during saldiuretic treatment]. Meyer P; Milliez P Nouv Presse Med; 1972 Sep; 1(32):2121-2. PubMed ID: 5082245 [No Abstract] [Full Text] [Related]
39. Combination diuretic drug therapy. Reubi FC Cardiovasc Clin; 1971; 2(3):197-210. PubMed ID: 4950425 [No Abstract] [Full Text] [Related]
40. [Diuresis and diuretics]. Schmidt P Wien Klin Wochenschr; 1971 Jun; 83(25):456-9. PubMed ID: 5130897 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]